Officials Eye New Biotech Tenants for Bristol-Myers' Former Connecticut Complex Post author:Sam Post published:February 15, 2018 Post category:BioPharma This week MA-based real estate firm Calare Properties acquired the land and buildings for $5M. Source: BioSpace You Might Also Like Esperion's Cholesterol Drug Positive in PhIII Trial March 6, 2018 SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test September 11, 2017 AstraZeneca PLC Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D May 21, 2017